Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
(NASDAQ: CRVS) Delayed: 12.56 +0.65 (5.46%)
Previous Close $11.91    52 Week High $17.77 
Open $12.46    52 Week Low $9.63 
Day High $12.83    P/E N/A 
Day Low $12.25    EPS $0.00 
Volume 1,388,656